Pharmacological Activation of Rapid Delayed Rectifier Potassium Current Suppresses Bradycardia-induced Triggered Activity in the Isolated Guinea Pig Heart.
From: NeuroSearch A/S, Pederstrupvej 93, 2750 Ballerup, Denmark.
The Journal of pharmacology and experimental therapeutics
- Publish Date: Jun 2007
- ISSN: 0022-3565
- Volume: 321
- Issue: 3
- Pages: 996-1002
- Medium: Print
- Language: English
- Citation (JAMA): Hansen Rie Schultz, Olesen Søren-Peter, Grunnet Morten, et al. Pharmacological Activation of Rapid Delayed Rectifier Potassium Current Suppresses Bradycardia-induced Triggered Activity in the Isolated Guinea Pig Heart.. J. Pharmacol. Exp. Ther. Jun 2007;321:996-1002
Abstract
Recently, attention has been drawn to compounds that activate the human ether-a-go-go channel potassium channel (hERG), which is responsible for the repolarizing rapid delayed rectifier potassium current (I(Kr)) in the mammalian myocardium. The compound NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N’-(3’-trifluoromethylphenyl) urea] increases the macroscopic current conducted by the hERG channels by increasing the time constant for channel inactivation, which we have reported earlier. In vitro studies suggest that pharmacological activation is an attractive approach for the treatment of some arrhythmias. We present here data that support that NS3623 affects native I(Kr) and report the effects that activating this potassium current have in the intact guinea pig heart. In Langendorff-perfused hearts, the compound showed a concentration-dependent shortening of action potential duration, which was also detected as concentration-dependent shorter QT intervals. There was no sign of action potential triangulation or reverse use dependence. NS3623 decreased QT variability and distinctly decreased the occurrence of extrasystoles in the acutely bradypaced hearts. Taken together, the present data strongly support the concept of using hERG activators as a treatment for certain kinds of arrhythmias and suggest further investigation of this new approach.
Mesh Headings (Keywords): Action Potentials, Animals, Anti-Arrhythmia Agents, Bradycardia, Electrocardiography, Ether-A-Go-Go Potassium Channels, Guinea Pigs, Heart, Heart Rate, Perfusion, Phenylurea Compounds, Piperidines, Pyridines, Tetrazoles, Ventricular Function
Check for Full Text / PubMed Unique Identifier (PMID): 17325228
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.